Resources by Therapeutic Area
A new ultra-high sensitivity troponin I assay for chest pain patients with no evidence of troponin I using a conventional assay
Clinical Biochemistry | December 4, 2014
There is considerable clinical interest in the development and possible implementation of highly sensitive cardiac troponin I (cTnI) assays for early rule out of acute coronary syndromes, short-term (30 days) risk stratification for future adverse cardiac events, and for detecting cardiac injury amo…
Clinical Chemistry and Laboratory Medicine | October 22, 2014
Immunoassays measuring cardiac troponins I or T have become firmly established as critical tools for diagnosing acute myocardial infarction.
2013 AACC Meeting, Houston, TX
L. Chang1, P. Patel1, L. Song1, Y. Chen1, D. Hanlon1, K. Minnehan1, M. Gardel1, B. Pink1, L. York1, S. Sullivan1, R. Meyer1, B. Flaherty1, J. Christopher1, D. H. Wilson1, M.J. Conrad,2 P.
Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: Results of a pilot study
Resuscitation | March, 2013
In this retrospective observational study, we employed a new ultra sensitive digital immunoassay technology to examine serial serum samples from 25 cardiac arrest patients to examine tau release into serum as a result of brain hypoxia, and probe for its significance predicting six-month neurological…
PLoS One | December 14, 2011
Amyloid β (Aβ) peptides are proteolytic products from amyloid precursor protein (APP) and are thought to play a role in Alzheimer disease (AD) pathogenesis. While much is known about molecular mechanisms underlying cerebral Aβ accumulation in familial AD, less is known about the cause(s) of brain am…